TLSI
TriSalus Life Sciences, Inc.
Key Financials
Gross Profit
$38.2M
↑ 50.8%
Net Income
$-39227000
↓ 30.6%
Operating Income
$-26946000
↑ 25.5%
Revenue
$45.2M
↑ 53.4%
Total Assets
$35.3M
↑ 47.4%
Cash & Equivalents
$20.4M
↑ 139.8%
Total Liabilities
$69.2M
↑ 38.8%
EPS (Diluted)
$-1.84
↓ 40.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| SCHEDULE 13G | 5/15/2026 | View on SEC |
| 4 | 5/15/2026 | View on SEC |
| 4 | 5/15/2026 | View on SEC |
| 4 | 5/15/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TLSI |
| Company Name | TriSalus Life Sciences, Inc. |
| CIK | 1826667 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 415 336 8917 |